Yuting Xia

Yuting Xia

Auto-generated profile, based on publicly available information

Yuting Xia

Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FLFei Li
Fei Li
YXYuting Xia
Yuting Xia
SYShijie Yuan
Shijie Yuan
XXXiaorong Xie
Xiaorong Xie
LLLin Li
Lin Li
RHRan He
Ran He
Metabolites play critical roles in macrophage polarization and in their function in response to infection and inflammation. α-aminobutyric acid (AABA), a non-proteinogenic amino acid which can be generated from methionine, threonine, serine, and glycine, has not been studied extensively in relation to macrophage polarization and function. In this study, we aimed to investigate the immunomodulatory function of AABA in regulating M1 macrophage polarization and function in vitro and in vivo. We stimulated bone-marrow-derived macrophages with lipopolysaccharide (LPS) to generate M1 macrophages. Subsequently, we induced sepsis and colitis in mice, followed by treatment with AABA. We then analyzed the samples using ELISA, real-time PCR, Western blotting, flow cytometry, and histopathological analysis to evaluate cytokine secretion, inflammatory gene expression, macrophage activation, disease progression, and inflammation severity. Additionally, metabolomic and chromatin immunoprecipitation-qPCR were conducted to investigate the function of AABA on metabolic reprogramming and epigenetic modifications of M1 macrophages. Our results revealed that AABA inhibited M1 macrophage polarization and function, which led to prolonged survival in septic mice and reduced disease severity in colitis mice. Mechanically, AABA promoted oxidative phosphorylation (OXPHOS) and glutamine and arginine metabolism while inhibiting glycolysis. Moreover, AABA could increase the occupancy of trimethylation of histone H3K27 at the promoter regions of M1 macrophage-associated inflammatory genes, which contributed to the inhibition of M1 macrophage polarization. These findings suggest that AABA may have therapeutic potential for inflammatory diseases by regulating macrophage polarization and function through metabolic and epigenetic pathways.

23 January 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
LZLiang Zhao
Liang Zhao
JLJun Li
Jun Li
BJBiling Jiang
Biling Jiang
JYJing Yang
Jing Yang
JLJiajia Lan
Jiajia Lan
JTJuan Tao
Juan Tao

21 November 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JLJiajia Lan
Jiajia Lan
BJBiling Jiang
Biling Jiang
XZXinyue Zhang
Xinyue Zhang
YXYuting Xia
Yuting Xia
ZCZhen Cai
Zhen Cai
JTJuan Tao
Juan Tao

1 December 2020 in European Journal Of Dermatology
Verified
Journal Article
Open access
LZLiang Zhao
Liang Zhao
HDHongyao Du
Hongyao Du
MAMahin Alamgir
Mahin Alamgir
JYJing Yang
Jing Yang
XMXiaoping Miao
Xiaoping Miao
JTJuan Tao
Juan Tao

1 July 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JCJianxia Chen
Jianxia Chen
YXYuting Xia
Yuting Xia
FZFaqiong Zhou
Faqiong Zhou
JTJuan Tao
Juan Tao
NZNuoya Zhou
Nuoya Zhou
Background: Patients with newly diagnosed generalized pustular psoriasis (GPP) lacking a history of psoriasis but with recent medication exposure may present with clinical features overlapping with acute generalized exanthematous pustulosis (AGEP). Accurate differentiation is critical for treatment and prognosis. Case Summary: We report two cases of drug-induced GPP initially with AGEP-like manifestations. Both patients received systemic glucocorticoids and cyclosporine yet exhibited recurrent pustular flares with lakes of pus and a prolonged disease course exceeding two months. Genetic testing confirmed IL36RN mutations in both cases. Subsequent spesolimab therapy achieved rapid resolution of pustules and sustained remission. Conclusion: In patients with first-onset drug-induced pustulosis resembling AGEP, the presence of lakes of pus, prolonged duration, and recurrent flares despite conventional therapies should be diagnosed as GPP promptly. Early intervention with spesolimab demonstrates efficacy in controlling disease activity and improving outcomes.

1 January 2026 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
FTFangshun Tan
Fangshun Tan
YJYu Jiang
Yu Jiang
RWRuizhi Wang
Ruizhi Wang
ZHZiquan Hu
Ziquan Hu
YXYuting Xia
Yuting Xia
WYWeixian Yang
Weixian Yang
Background: Psoriasis (PSO) and atherosclerosis (AS) are chronic inflammatory diseases that frequently coexist, with each condition exacerbating the other. However, the underlying mechanisms remain poorly understood, partly due to the lack of a suitable animal model that recapitulates this bidirectional comorbidity. Methods: PSO‐AS mouse models were constructed by combining high‐fat diet (HFD)–induced AS with imiquimod (IMQ)‐triggered psoriatic inflammation in ApoE −/− mice. PSO severity was assessed via skin manifestation, hematoxylin and eosin (H&E) staining, PSO area and severity index (PASI) score, quantitative real‐time PCR (qRT‐PCR), and serum ELISA, while AS was assessed by en face Oil red O (ORO) staining of aorta, H&E staining, ORO staining, Sirius Red (SR) staining, and immunofluorescence (IF) staining of the aortic root section. Mechanistic insights were obtained via proteomics, machine learning (ML), and validation of macrophage polarization in both skin and plaques. Results: Chronic PSO model more closely resembles real‐world conditions than acute PSO model. Combining the IMQ application with a HFD, both the PSO‐AS group and the PSO group developed obvious psoriatic skin lesion, but the PSO‐AS group showed the highest epidermal thickness, PASI scores, and expression levels of psoriatic biomarkers (Interleukin‐17A [IL‐17A] and Interleukin‐23 [IL‐23]) and inflammatory factors (e.g., tumor necrosis factor alpha [TNF‐α] and Interleukin‐6 [IL‐6]), implying that AS may exacerbate PSO. Similarly, the PSO‐AS and AS groups both developed obvious plaque in the aorta, while the PSO‐AS group has the largest plaque area, necrotic core (NC) area, lipid content with the least fibrous cap (FC) thickness, and collagen content, illustrating that PSO conspicuously aggravated AS progression and led to an unstable plaque shift. Statistical analysis also confirms that PSO and AS mutually exacerbate each other, forming a vicious cycle that may be strongly associated with IL‐17. Proteomics and ML revealed marked M1 macrophage polarization in PSO‐AS mice. Validation by Western blot and IF showed upregulated M1 markers (CD86) and downregulated M2 markers (CD163) in both skin lesions and aortic roots, indicating that M1‐skewed macrophages fuel the vicious cycle. Besides, we explore that IFIT3 may serve as a promising biomarker for M1 macrophages in PSO‐AS skin. Conclusions: This novel PSO‐AS mouse model faithfully recapitulates the bidirectional exacerbation seen clinically and uncovers M1 macrophage polarization as a key driver of this comorbidity. The model provides a robust platform for mechanistic and therapeutic studies of PSO‐associated cardiovascular disease (CVD).